论文信息 - Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol - 字舞流文

Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol

A. Walker | N. Klein | J. Standing | J. Herberg | D. Eleftheriou | P. Brogan | M. Wan | Filip Kucera | R. Kahn | M. Mossberg | R. Tulloh | Cara Purvis | Marta Merida Morillas | M. Pursell | Roisin Connon | Michael Levin | Rachael McCormack | Y. C. Moraes | Robin Kahn | Veronica Swallow | M. Wan | Maria Mossberg | A. Walker